3 results match your criteria: "University of Pittsburgh Western Psychiatric Institute and Clinic[Affiliation]"

Flibanserin and its discontents.

Arch Womens Ment Health

April 2017

Center of Excellence in Public Service Psychiatry, University of Pittsburgh Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.

In August 2015, flibanserin (brand name Addyi) was approved by the Food and Drug Administration (FDA) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This article summarizes and promotes discussion regarding the numerous controversies that have enclosed flibanserin since the very beginning. This includes questions related to flibanserin's safety and efficacy and the validity of the clinical trials.

View Article and Find Full Text PDF

Objective: The growth of computer technology allows clinicians to develop a separate information system to replace inefficient paper-based approaches to documenting clinical care.

Methods: A clinician team developed a system to replace standard paper forms using computer software running on 486 PC computer. Clinicians, directing the project at every step, refined handwritten forms to create a complete word processor application merging information from an individual database.

View Article and Find Full Text PDF